Indivior Fights For Sales Docs In Product-Hopping Case
By Melissa Lipman ( January 29, 2016, 7:59 PM EST) -- Reckitt Benckiser spinoff Indivior has again urged a Pennsylvania federal judge to force drug wholesalers and others who claim the companies used a so-called product-hopping scheme to stifle generic competition to Suboxone to turn over information about downstream sales of the opiate addiction treatment....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.